Targeting the tumor microenvironment: from understanding pathways to effective clinical trials

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment Research

Background:

• Tumor cells are not isolated but interact extensively with the extracellular matrix and stromal cells within the tumor microenvironment (TME).
• Understanding these complex tumor cell-stroma interactions has grown significantly over the past two decades.
• This increased knowledge has spurred the development of therapeutic agents designed to disrupt these crucial interactions.

Purpose of the Study:

• To review therapeutic strategies targeting the tumor microenvironment (TME).
• To focus on agents that have reached advanced stages of preclinical or clinical development.
• To outline key lessons learned from developing TME-targeting agents.

Main Methods:

• Review of scientific literature on TME-targeting therapies.
• Focus on agents in advanced preclinical or clinical development.
• Analysis of therapeutic strategies interfering with tumor cell-stroma interactions.

Main Results:

• Identification of four distinct therapeutic strategies targeting the TME.
• Highlighting agents currently in advanced stages of development.
• Discussion of the progress and challenges in TME-targeted therapy.

Conclusions:

• Therapeutic strategies targeting the tumor microenvironment (TME) are progressing rapidly.
• Agents interfering with tumor cell-stroma interactions show promise in cancer treatment.
• Lessons learned from TME-targeting agent development are crucial for future therapeutic advancements.